| 引用本文: | 李美芳,陈蕾,凌霄,蒋赟.药典讨论组的药用辅料标准工作的进展及其对中国药典的启示[J].中国现代应用药学,2023,40(5):689-696. |
| LI Meifang,CHEN Lei,LING Xiao,JIANG Yun.Progress on Pharmacopeial Discussion Group Standards for Pharmaceutical Excipients and its Enlightenment to Chinese Pharmacopoeia[J].Chin J Mod Appl Pharm(中国现代应用药学),2023,40(5):689-696. |
|
| 本文已被：浏览 1473次 下载 988次 |
码上扫一扫！ |
|
|
| 药典讨论组的药用辅料标准工作的进展及其对中国药典的启示 |
|
李美芳1, 陈蕾2, 凌霄3, 蒋赟4
|
|
1.深圳市药品检验研究院, 广东 深圳 518057;2.国家药典委员会, 北京 100061;3.美药典中华区, 上海 200131;4.国家药品监督管理局药用辅料工程技术研究重点实验室, 湖南省药品检验检测研究院, 长沙 410001
|
|
| 摘要: |
| 目的 借鉴药典讨论组(pharmacopeial discussion group，PDG)对欧洲药典、美国药典和日本药局方药用辅料标准协调的经验，探析中国药典协调工作的思路和方法。方法 查阅PDG协调工作背景、工作程序、工作进展，分析三方药典协调标准的特点，梳理PDG药用辅料标准与中国药典异同点。结果 中国药典2020年版四部相应药用辅料标准有一定的先进性，也有提升空间。结论 建议结合中国国情，加强与PDG联系，明确标准协调的原则，提高中国药用辅料标准水平，稳步推进中国药用辅料标准国际协调工作。 |
| 关键词: 药典讨论组 药用辅料 标准协调 |
| DOI：10.13748/j.cnki.issn1007-7693.20222456 |
| 分类号:R94 |
| 基金项目: |
|
| Progress on Pharmacopeial Discussion Group Standards for Pharmaceutical Excipients and its Enlightenment to Chinese Pharmacopoeia |
|
LI Meifang1, CHEN Lei2, LING Xiao3, JIANG Yun4
|
|
1.Shenzhen Institute for Drug Control, Shenzhen 518057, China;2.Chinese Pharmacopoeia Commission, Beijing 100061, China;3.USP-China Office, Shanghai 200131, China;4.NPMA Key Laboratory for Pharmaceutical Excipients Engineering Technology Research, Hunan Institute for Drug Control, Changsha 410001, China
|
| Abstract: |
| OBJECTIVE To explore the ideas and methods of international harmonization of the Chinese Pharmacopoeia, drawing on the experience of the pharmacopeial discussion group(PDG) on the harmonization standards for pharmaceutical excipients in the European Pharmacopoeia, the United States Pharmacopeia and the Japanese Pharmacopoeia. METHODS By reviewing the PDG working background, procedures, and progress, analyze the characteristics of harmonization standards, and sorted out the similarities and differences between the harmonization standards and the Chinese Pharmacopoeia for pharmaceutical excipients. RESULTS The corresponding standards for pharmaceutical excipients in the Chinese Pharmacopoeia(2020 edition) volume Ⅳ had a certain advancement, and still need to be further improved. CONCLUSION It is recommended that Chinese Pharmacopoeia Commission strengthen the connection with PDG, combine the national conditions of China, clarify the principles of standards harmonization, improve the level of pharmaceutical excipients standards, and steadily promote the progress of the international harmonization standards of pharmaceutical excipients. |
| Key words: pharmacopeial discussion group(PDG) pharmaceutical excipients harmonization standards |
